Humeau Laurent
Chief Scientific Officer
Officer
Latest Insider Transactions
10 transactions (past 365 days)
| 2026-05-21 | 2026-05-20 | INO Inovio Pharmaceuticals, Inc. | CSO | Award | 34,160 | $1.73 | $59,097 |
| 2026-05-21 | 2026-05-20 | INO Inovio Pharmaceuticals, Inc. | CSO | Tax Payment | 2,163 | $1.23 | $2,660 |
| 2026-05-21 | 2026-05-20 | INO Inovio Pharmaceuticals, Inc. | CSO | Exercise Conversion | 6,027 | $0.00 | $0 |
| 2026-05-18 | 2026-05-15 | INO Inovio Pharmaceuticals, Inc. | CSO | Tax Payment | 1,712 | $1.30 | $2,226 |
| 2026-05-18 | 2026-05-15 | INO Inovio Pharmaceuticals, Inc. | CSO | Exercise Conversion | 4,771 | $0.00 | $0 |
| 2026-03-05 | 2026-03-04 | INO Inovio Pharmaceuticals, Inc. | CSO | Award | 26,840 | $1.73 | $46,433 |
| 2026-02-27 | 2026-02-26 | INO Inovio Pharmaceuticals, Inc. | CSO | Tax Payment | 3,034 | $1.79 | $5,431 |
| 2026-02-27 | 2026-02-26 | INO Inovio Pharmaceuticals, Inc. | CSO | Tax Payment | 2,064 | $1.79 | $3,695 |
| 2026-02-27 | 2026-02-26 | INO Inovio Pharmaceuticals, Inc. | CSO | Exercise Conversion | 5,010 | $0.00 | $0 |
| 2026-02-27 | 2026-02-26 | INO Inovio Pharmaceuticals, Inc. | CSO | Exercise Conversion | 7,366 | $0.00 | $0 |
INO
CSO
Tax Payment
$2.7K
2,163 shares @ $1.23
Filed 2026-05-21Trade 2026-05-20
Inovio Pharmaceuticals, Inc.INO
CSO
Exercise Conversion
$0
6,027 shares @ $0.00
Filed 2026-05-21Trade 2026-05-20
Inovio Pharmaceuticals, Inc.INO
CSO
Tax Payment
$2.2K
1,712 shares @ $1.30
Filed 2026-05-18Trade 2026-05-15
Inovio Pharmaceuticals, Inc.INO
CSO
Exercise Conversion
$0
4,771 shares @ $0.00
Filed 2026-05-18Trade 2026-05-15
Inovio Pharmaceuticals, Inc.INO
CSO
Tax Payment
$5.4K
3,034 shares @ $1.79
Filed 2026-02-27Trade 2026-02-26
Inovio Pharmaceuticals, Inc.INO
CSO
Tax Payment
$3.7K
2,064 shares @ $1.79
Filed 2026-02-27Trade 2026-02-26
Inovio Pharmaceuticals, Inc.INO
CSO
Exercise Conversion
$0
5,010 shares @ $0.00
Filed 2026-02-27Trade 2026-02-26
Inovio Pharmaceuticals, Inc.INO
CSO
Exercise Conversion
$0
7,366 shares @ $0.00
Filed 2026-02-27Trade 2026-02-26
Inovio Pharmaceuticals, Inc.